Yamada K, Sato T, Yamada A, Tanaka S, Fujii S, Matuo R, Murata K, Manabe T, Oda J
Dept. of Internal Medicine, Osaka City General Hospital.
Gan To Kagaku Ryoho. 1999 Feb;26(3):361-4.
In February, 1996, a 73-year-old male with liver dysfunction was admitted to our hospital for further examination and treatment of liver tumor. The liver tumor was revealed by imaging examination, which was mainly in the S4-S8 of liver with a thrombus growing from the right anterior branch to the right branch of the portal vein, and from the right hepatic vein to the inferior vena cava and right atrium. The serum AFP and PIVKA-II levels were elevated to 3.610 ng/ml and 54 AU/ml, respectively. The patient was diagnosed as having hepatocellular carcinoma, and was treated by arterial administration of anticancer drugs (epirubicin hydrochloride, mitomycin C and carboplatin) and TAE. Though the main tumor (S4-S8 of liver) was reduced by TAE, the portal and atrial tumor thrombus did not respond. One month after TAE (20 May, 1996), the first arterial administration of Lipiodol-SMANCS was given, followed by 4 successive procedures with an interval of about 1.5 months (total dose 15 mg), resulting in remarkable tumor thrombus shrinkage and reduction of AFP levels to 80 ng/ml. This case shows that arterial administration of SMANCS may be one of the effective treatments for hepatocellular carcinoma, even with tumor thrombus of hepatic vein, IVC and right atrium.
1996年2月,一名肝功能不全的73岁男性因肝脏肿瘤进一步检查及治疗入住我院。影像学检查发现肝脏肿瘤,主要位于肝脏S4 - S8段,门静脉右前支至右支有血栓形成,且从右肝静脉至下腔静脉及右心房也有血栓。血清甲胎蛋白(AFP)和异常凝血酶原(PIVKA-II)水平分别升高至3.610 ng/ml和54 AU/ml。该患者被诊断为肝细胞癌,并接受了动脉内抗癌药物(盐酸表柔比星、丝裂霉素C和卡铂)注射及经动脉化疗栓塞(TAE)治疗。尽管TAE使主要肿瘤(肝脏S4 - S8段)缩小,但门静脉和心房肿瘤血栓并无反应。TAE后1个月(1996年5月20日),首次动脉内注射碘油-丝裂霉素多柔比星混悬液(Lipiodol-SMANCS),随后连续进行4次,间隔约1.5个月(总剂量15 mg),结果肿瘤血栓明显缩小,AFP水平降至80 ng/ml。该病例表明,即使存在肝静脉、下腔静脉及右心房肿瘤血栓,动脉内注射丝裂霉素多柔比星混悬液也可能是肝细胞癌的有效治疗方法之一。